Abstract
Objectives
The aim of this study was to examine the impact of overlapping bare-metal stent (BMS) and three different formulations of drug-eluting stent (DES) on intimal hyperplasia (IH) response of patients with diabetes mellitus (DM).
Methods
Forty-nine DM patients treated with overlapping BMS (19 lesions), sirolimus-eluting stent (SES 12 lesions), paclitaxel-eluting stent (PES 8 lesions) or tacrolimus-eluting stent (TES 10 lesions) were studied. Baseline and 9-month follow-up volumetric intravascular vascular ultrasound (IVUS) and quantitative coronary angiography (QCA) analysis were performed in the entire stented segment and in the overlapped (OL) and non-overlapped (non-OL) subsegments. Clinical outcomes were evaluated at 1-year follow-up.
Results
Post-procedure (PO-) QCA measurements were similar in all stent groups, and between OL and non-OL subsegments in each individual type of stents. Percent IH was lower in SES and PES vs. BMS (p < 0.05). Percent IH was significantly greater in OL subsegment compared with non-OL subsegment in BMS (p < 0.05), but not in all type of DES groups. SES showed significantly less %IH compared with PES and TES in OL and non-OL subsegments. Vessel area at the OL remained unchanged from PO to FU in all type of DES and BMS groups. There were no aneurysm formation and no stent thrombosis up to 1-year follow-up.
Conclusions
Overlapping BMS is associated with enhanced IH response in diabetic patients, whereas overlapping DES, particularly SES and PES, appear effective to inhibit IH without detectable late vascular adverse effects.
Similar content being viewed by others
References
Kip KE, Faxon DP, Detre KM et al (1996) Coronary angioplasty in diabetic patients. The national heart, lung, and blood institute percutaneous transluminal coronary angioplasty registry. Circulation 94:1818–1825
Angiolillo DJ, Bernardo E, Ramirez C et al (2006) Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment. J Am Coll Cardiol 48:298–304
Mathew V, Gersh BJ, Williams BA et al (2004) Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the prevention of restenosis with tranilast and its outcomes (PRESTO) trial. Circulation 109:476–480
Stone GW, Ellis SG, Cox DA et al (2004) A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350:221–231
Colombo A, Drzewiecki J, Banning A et al (2003) Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 108:788–794
Schampaert E, Cohen EA, Schluter M et al (2004) The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 43:1110–1115
Schofer J, Schluter M, Gershlick AH et al (2003) Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 362:1093–1099
Morice MC, Serruys PW, Sousa JE et al (2002) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773–1780
Moses JW, Leon MB, Popma JJ et al (2003) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349:1315–1323
Sabate M, Jimenez-Quevedo P, Angiolillo DJ et al (2005) Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial. Circulation 112:2175–2183
Ellis SG, Savage M, Fischman D et al (1992) Restenosis after placement of Palmaz-Schatz stents in native coronary arteries. Initial results of a multicenter experience. Circulation 86:1836–1844
Finn AV, Kolodgie FD, Harnek J et al (2005) Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 112:270–278
Corros C, Sabate M, Jimenez-Quevedo P et al (2005) Efficacy of paclitaxel-eluting stent implantation in diabetic patients with de novo coronary stenoses. Final results of the DIABETES II trial. Am J Cardiol 96:41H
Sabate M, Ferrer MC, Jimenez-Quevedo P et al (2006) Efficacy of tacrolimus-eluting stent to prevent restenosis in diabetic patients. Final results of the DIABETES-3 trial. Am J Cardiol 98:117M
Abizaid A, Albertal M, Costa MA et al (2004) First human experience with the 17-beta-estradiol-eluting stent: the estrogen and stents to eliminate restenosis (EASTER) trial. J Am Coll Cardiol 43:1118–1121
Futamatsu H, Sabate M, Angiolillo DJ et al (2006) Characterization of plaque prolapse after drug-eluting stent implantation in diabetic patients: a three-dimensional volumetric intravascular ultrasound outcome study. J Am Coll Cardiol 48:1139–1145
Jimenez-Quevedo P, Sabate M, Angiolillo DJ et al (2006) Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the diabetes and sirolimus-eluting stent (DIABETES) trial. J Am Coll Cardiol 47:2172–2179
Kozuma K, Costa MA, Sabate M et al (1999) Late stent malapposition occurring after intracoronary beta-irradiation detected by intravascular ultrasound. J Invasive Cardiol 11:651–655
Mintz GS, Nissen SE, Anderson WD et al (2001) American college of cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A report of the American college of cardiology task force on clinical expert consensus documents. J Am Coll Cardiol 37:1478–1492
Costa MA, Sabate M, Angiolillo DJ et al (2006) Intravascular ultrasound characterization of the “black hole” phenomenon after drug-eluting stent implantation. Am J Cardiol 97:203–206
Costa MA, Sabate M, Angiolillo DJ et al (2007) Relocation of minimal lumen diameter after bare metal and drug-eluting stent implantation: incidence and impact on angiographic late loss. Catheter Cardiovasc Interv 69: 181–188
Kastrati A, Mehilli J, von Beckerath N et al (2005) Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 293:165–171
Sabate M, Costa MA, Kozuma K et al (2000) Methodological and clinical implications of the relocation of the minimal luminal diameter after intracoronary radiation therapy. Dose finding study group. J Am Coll Cardiol 36:1536–1541
Kastrati A, Elezi S, Dirschinger J et al (1999) Influence of lesion length on restenosis after coronary stent placement. Am J Cardiol 83:1617–1622
Kastrati A, Schomig A, Elezi S et al (1997) Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 30:1428–1436
Haude M, Erbel R, Straub U et al (1991) Short and long term results after intracoronary stenting in human coronary arteries: monocentre experience with the balloon-expandable Palmaz-Schatz stent. Br Heart J 66:337–345
Colombo A, Orlic D, Stankovic G et al (2003) Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Circulation 107:2178–2180
Serruys PW, Degertekin M, Tanabe K et al (2002) Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (Randomized study with the sirolimus-eluting velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions) trial. Circulation 106:798–803
Munoz JS, Abizaid A, Mintz GS et al (2004) Intravascular ultrasound study of effects of overlapping sirolimus-eluting stents. Am J Cardiol 93:470–473
Kereiakes DJ, Wang H, Popma JJ et al (2006) Periprocedural and late consequences of overlapping Cypher sirolimus-eluting stents: pooled analysis of five clinical trials. J Am Coll Cardiol 48:21–31
Bouma BE, Tearney GJ, Yabushita H et al (2003) Evaluation of intracoronary stenting by intravascular optical coherence tomography. Heart 89:317–320
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kawaguchi, R., Sabate, M., Angiolillo, D.J. et al. Angiographic and 3D intravascular ultrasound assessment of overlapping bare metal stent and three different formulations of drug-eluting stents in patients with diabetes mellitus. Int J Cardiovasc Imaging 24, 125–132 (2008). https://doi.org/10.1007/s10554-007-9235-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-007-9235-7